Nifursol

CAS No. 16915-70-1

Nifursol( —— )

Catalog No. M20550 CAS No. 16915-70-1

Nifursol is a livestock feed additive and antiobiotic used to prevent the growth of histomonas.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 27 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Nifursol
  • Note
    Research use only, not for human use.
  • Brief Description
    Nifursol is a livestock feed additive and antiobiotic used to prevent the growth of histomonas.
  • Description
    Nifursol is a livestock feed additive and antiobiotic used to prevent the growth of histomonas.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    16915-70-1
  • Formula Weight
    365.21
  • Molecular Formula
    C12H7N5O9
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:36 mg/mL (98.57 mM)
  • SMILES
    Oc1c(cc(cc1[N+]([O-])=O)[N+]([O-])=O)C(=O)N\N=C\c1ccc(o1)[N+]([O-])=O
  • Chemical Name
    (E)-2-hydroxy-35-dinitro-N'-((5-nitrofuran-2-yl)methylene)benzohydrazide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Sullivan T W Mitchell R J Grace O D . Prophylactic Efficacy of Nifursol Against Different Levels of Exposure to Histomoniasis in Turkeys 4 to 9 Weeks of Age[J]. Poultry Science 1972 51(6):1956-1959.
molnova catalog
related products
  • IRAK4-IN-4

    IRAK4-IN-4 inhibits cyclic GMP-AMP synthase (cGAS) with an IC50 of 2.1 nM.IRAK4-IN-4 is an interleukin-1 receptor–associated kinase 4 (IRAK4) inhibitor, has an IC50 of 2.8 nM.

  • Ganodermanondiol

    Ganodermanondiol exhibits potent cytoprotective effects on t-BHP-induced hepatotoxicity in human liver-derived HepG2 cells, presumably through Nrf2-mediated antioxidant enzymes and AMPK.

  • BRD0639

    BRD0639 is a pioneering inhibitor targeting the interaction between PRMT5 and its substrate adaptor.